Health Care & Life Sciences » Biotechnology | Selecta Biosciences Inc.

Selecta Biosciences Inc.

Selecta Biosciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.52
Market Cap
$77.93 M
Shares Outstanding
44.79 M
Public Float
33.64 M

Profile

Address
480 Arsenal Way
Watertown Massachusetts 02472
United States
Employees -
Website http://www.selectabio.com
Updated 07/08/2019
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The firm produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. Its proprietary pipeline includes SVP-enabled enzyme, oncology, and gene therapies.

Financials

View All

Omid C. Farokhzad
Chairman
Werner Cautreels
President, Chief Executive Officer & Director